title: Development of dopamine innervation and turning behavior in dopamine-depleted infant rats receiving unilateral nigral transplants.
abstract: Three-day-old rats were bilaterally dopamine-depleted with 6-hydroxydopamine and 3 days later cell suspensions derived from the dopamine-rich ventral mesencephalic area were injected into the right rostral striatum. The transplants rapidly developed a substantial innervation of one striatum, so that by 15 days after transplantation (21 days of age) animals rotated away from the reinnervated side in response to amphetamine. The amount of turning correlated with the extent of innervation of the striatum as determined by tyrosine hydroxylase immunocytochemistry. By 25 days post-transplantation (31 days of age), animals turned in response to stress as well as amphetamine, although this later-developing phenomenon was not associated with any significant change in the extent of dopamine innervation. A second group of animals was bilaterally dopamine-depleted at 3 days of age, but transplantation with nigral cell suspensions was delayed until maturity. Partial reinnervation of the rostral striatum occurred with this delayed transplant paradigm, and turning to both amphetamine and stress commenced at 15 days post-transplantation. In contrast to animals receiving transplants shortly after lesioning, these animals began to turn spontaneously at about 20 days post-transplantation. The serotonin hyperinnervation that occurs following dopamine depletion in infancy was not altered by dopamine transplants made at either time. Results from both groups of transplant animals suggest that dopamine-rich transplants can provide substantial innervation that exerts some functional control over the striatum. This occurs despite the fact that neonatally dopamine-depleted rats, unlike adult-lesioned animals, survive quite well in the absence of striatal dopamine. However, the degree of incorporation into existing circuitry, and the types of regulation that result, may vary considerably depending on the age at which the tissue is transplanted.
authors.affiliation: Department of Neurobiology, University of Pittsburgh School of Medicine, PA 15261.
authors.forename: A M
authors.initials: AM
authors.lastname: Snyder-Keller
authors.forename: R K
authors.initials: RK
authors.lastname: Carder
authors.forename: R D
authors.initials: RD
authors.lastname: Lund
mesh_terms: D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D006085:Graft Survival; D006892:Hydroxydopamines; D008636:Mesencephalon / Q000378:metabolism / Q000637:transplantation*; D009498:Neurotoxins; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D013239:Stereotyped Behavior / Q000502:physiology*; D013378:Substantia Nigra / Q000378:metabolism / Q000502:physiology*; D013997:Time Factors
chemical_list: D006892:Hydroxydopamines; D009498:Neurotoxins; D016627:Oxidopamine; D004298:Dopamine